Noleus Technologies的动态

Learn how to push the boundaries of innovation in #MedTech, even in the face of failure. Scott Nelson in an article for MD+DI, shares advice from some of the industry’s most innovative entrepreneurs: ??Innovate with Purpose: Foster a culture of innovation that resonates with the real needs of patients, providers, and hospitals. ??Make it personal and ask the right questions: Lean into your personal drive and anchor your conviction in expert opinions. ??Lean into Your Passion: Follow your curiosity and leverage your diverse skill set to develop practical solutions. ??Balance Vision with Constructive Feedback: Analyze different perspectives to refine your solution. ??Take it One Smart Step at a Time: Embrace a systematic approach to innovation through continuous refinement and improvement. Read more below: https://lnkd.in/gmPkCZwR

“You now need to think more about how your device is going to be used and how it's going to be incorporated into the practice of medicine. So first and foremost, if your technology converts an in-hospital to an out-of-hospital procedure, or it allows earlier discharge or in some way, shape, or form shortens that episode of care within the hospital, that's really, really important. Even if your technology is better but it adds a two-day stay, that may be a tough sell.” Meet the CEO of Canary Medical Inc., Dr. Bill Hunter, who was previously instrumental in the development of #medicaldevices like the TAXUS drug-eluting coronary stent, paclitaxel-eluting balloons, and the Zilver PTX peripheral drug-eluting stent. Bill’s extensive career as a practitioner and notable successes in the #medtech space are truly impressive. After spearheading the successes of companies Angiotech Pharmaceuticals and CORREVIO PHARMA CORP., he’s now at the forefront of bringing novel digital solutions to healthcare. At Canary, Bill and his team are developing smart implants that empower patients by providing real-time insights during their recovery journey after implant surgeries. Here’s a taste of Bill’s interview with Scott Nelson: ?? Identify market opportunities by examining trends and structural gaps. Bill, for example, noticed the demand for personalized patient care and the strain on healthcare providers, leading him to develop digital solutions. ??Innovation in medtech requires a superior, not just an alternative, product approach framework. Consider how your idea streamlines processes, reduces hospital stays, and empowers both patients and physicians. ?? If you’re a physician contemplating a full-time move to a startup, embrace your entrepreneurial spirit by leveraging the stability of your medical career. Start small, experiment, and be honest with yourself about your priorities. Check out the full interview link with Bill in the comments below. This Medsider episode was brought to you by FastWave Medical, a hot IVL startup in the cardiovascular space. Don’t miss out on their next fundraise (more details in the comments). P.S. - We just launched Medsider Mentors Volume VI, which is packed with insights and learnings from founders and CEOs of some of the most dynamic medical device and health technology startups in the world. Click the link in the comment section for this latest edition now available exclusively to our premium members.

For those who are new to our page- we are VonVascular.io, a medtech startup with a goal of revolutionizing #stroke and #PAD treatment. Here are some of the key values that comprise our #companyculture: ?? Research: We're committed to building evidence, ensuring our devices lead the way in performance and efficacy. ?? Innovative Solutions: We aim to produce #pioneeringtechnology that pushes the boundaries of what's possible in medtech. ?? Transforming Lives: We are committed to technologies that foster personalized medicine for improved patient outcomes. ?? Sustainability: From eco-friendly materials to sustainable R&D and production, we’re dedicated to reducing our environmental footprint. Join us in this journey to transform healthcare. Learn more by visiting our website www.vonvascular.io and follow our page for the latest updates! #HealthcareInnovation #MedTech #VascularSurgery #PersonalizedMedicine

?? Innovation in healthcare often means getting comfortable with being uncomfortable. John Erbey, founder and CEO of his pioneering kidney care company Roivios, Ltd., embodies this principle. With over 25 years in the medical field, John is transforming how we approach kidney disease- a $250 billion annual challenge in the US alone. In our latest Passionate Pioneers with Mike Biselli episode, John shares his journey from epidemiologist to entrepreneur, and how his personal experiences drive his mission to revolutionize patient care. ?? TUNE IN HERE ?? https://lnkd.in/gchZwidt Key highlights from our conversation: ?? Developing a groundbreaking renal assist device for cardiac surgery patients ?? Aiming to reduce ICU stays and improve outcomes for high-risk kidney patients ?? Envisioning wearable and implantable kidney support technologies ?? Embracing discomfort as a catalyst for true healthcare innovation ?? Tackling this large financial healthcare challenge with innovative solutions From discussing the critical role of kidneys in overall health to outlining a future where kidney function can be sustained and enhanced, John's insights are both inspiring and thought-provoking! ?? ?? Ready to dive deeper into the future of kidney care? Join us for this important and exciting conversation! ?? This episode's Community Champion Sponsor is ?ssur! To learn more about Ossur's ?? 'Responsible for Tomorrow' sustainability initiative ?? , and how you can get involved ?? https://lnkd.in/grgSiac #innovation #healthcare #medtech #entrepreneurship #startups #leadership #technology #research #medicine #biotechnology #kidneycare #podcast

?? Ground-breaking Trial Results Alert! ???? Some news in the HealthTech realm that's truly worth talking about. Cordis has just showcased phenomenal 2-year outcomes from their Selution SLR trial. Imagine a drug-eluting balloon that's setting new norms in vascular therapy - it's here, and it's proving its mettle! Offering hope for patients with femoral and popliteal artery disease, these DEB advancements might just be the beacon for endovascular therapies. With sustained drug release akin to stents and a whopping 83% primary patency rate at 24 months, we're looking at a 'Selution' that's not just smart, but showing incredible longevity. ?? And here's a nod to innovation - those micro-reservoirs are playing the long game in drug delivery. For those affected by peripheral artery disease or looking for better post-stent options, this news could be game-changing. As a passionate tech headhunter, I'm thrilled to see such tech evolving and proving itself on such a critical stage. I often say it's the real-world impact that counts, and Selution SLR seems to be ticking some serious boxes in patient care. ?? For fellow execs and innovators in the MedTech field, isn't this the kind of development that keeps our industry pulsing with potential? #HealthTech #Innovation #PatientCare

?? Embracing Disruptive Innovation: The Imperative Choice of Adaptation over Resistance. ??Clayton Christensen's theory of disruptive innovation suggests that new technologies or approaches can disrupt existing markets by offering simpler, more affordable solutions that initially cater to overlooked or underserved segments. ??In the context of interventional pain and specialties like spine surgery, disruptive innovations might involve less invasive procedures, outpatient alternatives, or technology-driven solutions that challenge traditional, more invasive methods. These innovations could potentially improve patient outcomes and reduce costs, creating a shift in the healthcare landscape. ??Pearls: 1. **Introduction of a New Technology or Approach:** ??Disruption begins with the introduction of a new, often simpler or more affordable, technology or approach that may initially seem inferior to existing solutions. 2. **Focus on Underserved Markets:** ??The new innovation typically targets underserved or overlooked market segments that are not well-addressed by existing products or services. This allows the disruptive technology to gain a foothold. 3. **Incremental Improvement:** ??Over time, the disruptive technology undergoes incremental improvements, gradually closing the performance gap with established solutions. This may initially go unnoticed by incumbents in the industry. 4. **Rapid Advancement:** ??The disruptive innovation eventually advances rapidly, surpassing the capabilities of established products or services. This can lead to a significant shift in the market dynamics. 5. **Mainstream Adoption:** ??As the disruptive technology matures, it gains acceptance in mainstream markets, causing a fundamental transformation in the industry and often leading to the decline of established players who fail to adapt. ??These steps illustrate the process by which disruptive innovations, initially considered inferior, evolve and ultimately reshape industries by meeting the evolving needs of consumers in a more efficient or effective manner. Is disruptive innovation, per Clay's theory, impacting interventional pain management as it has in diverse medical fields, hinting at potential disruptions in procedures performed by today's internationalists? ?? Answer: Certainly. Without a doubt, comprehending this theory allows for either adaptation or risking failure by attempting to combat it, as this marks the initial phase of the disruptive innovation process. Incumbents typically initially attempt to thwart it through various avenues, but these endeavors consistently prove unsuccessful. #medicalindustry #disruption #turfmanagement #innovation #technology

Folks, one thing has become crystal clear as we navigate the aftermath of COVID: health should be at the top of our priority list. For many of us, this goes not just for ourselves but for our loved ones. MedTech innovators in Baltimore understand this well, so it's no wonder Baltimore is leading the MedTech innovation scene. In March, Maryland was even chosen to host MedTech Innovator (MTI) and BioTools Innovator (BTI). The city wants to create the right environment for companies that want to bring technologies to market that can help many lives. Companies that not just make better inventions but tackle real challenges of healthcare costs and efficiency. I can't help but admire the people making these significant steps forward. They don't just enhance healthcare overall, but they do it with empathy and inclusivity. https://lnkd.in/edJDfS5i. #Baltimore #MedTech #Founders #MedicalDevices #HarborDesigns

?? Top MedTech Deals of H1 2024! ?? The MedTech industry has seen some major moves in the first half of 2024. Here are some of the standout deals: 1. Johnson & Johnson bought Shockwave Medical for $13.1 billion, helping them grow even bigger in heart devices. 2. Boston Scientific spent $3.7 billion on buying Axonics, Inc., making their urology treatments even better. They also got Silk Road Medical, Inc. for $1.26 billion to help prevent strokes. 3. Agiliti is going private in a $2.5 billion deal, marking a significant shift for the company. 4. Roche bought LumiraDx's point-of-care tech for $295 million, aiming to improve their testing capabilities. 5. Haemonetics spent $160 million to get Attune Medical, adding cool oesophagus tech to their collection. We're seeing companies across MedTech starting to position themselves strategically for growth and innovation. Exciting times ahead for the industry! ?? Would love to hear your thoughts on these M&As in the comments below! #MedTech #Healthcare #medicaldevices

Here’s a recent op-ed our CEO, Scott Nelson, published on MD+DI. In addition to the 5 key learnings featured below, he also touches on: ????♂?How to set measurable goals for each stage of device development. ??The formula for a systematic approach that lets you decide what to pursue and when to pivot. ?? How to combine personal satisfaction with professional success. Click on the link ? for a closer a look at these insights from leading #medtech entrepreneurs.

In my latest @MD+Di article, I explore some of the key characteristics of #medtech leaders that helped them push the boundaries of innovation. Here’s a snapshot of the key learnings covered in this op+ed: ?? David Neale, CEO of Argá Medtech SA, outlines how he created a winning culture. Challenge your team team to step out of its comfort zone and answer tough questions that lead to creative solutions. ?? Kate Rumrill, CEO of Ablative Solutions, believes in pursuing fields that hold personal meaning. Lean into your passion and let it drive your venture. ?? Shriram Raghunathan, Ph.D, CEO of Noctrix Health, Inc., encourages leveraging one’s curiosity and interests in other domains to create practical solutions. But first, find a big problem that needs solving. ?? Dr. Krishan Ramdoo, CEO? of TympaHealth Technologies Ltd, talks about sifting through the noise of naysayers. Start small, iterate, and embrace constructive feedback as fuel for progress. ?? David Narrow, CEO of Sonavex, emphasizes flexibility in product design. Define clear goals, invest in feedback loops, and refine continuously for success. For more actionable advice from these ambitious doers, check out the full article here: https://lnkd.in/dSzgppub? As always, thanks to Omar Ford and Amanda Pedersen for their publishing support! ????